These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of saliva in therapeutic drug monitoring. Horning MG; Brown L; Nowlin J; Lertratanangkoon K; Kellaway P; Zion TE Clin Chem; 1977 Feb; 23(2 PT. 1):157-64. PubMed ID: 318941 [TBL] [Abstract][Full Text] [Related]
3. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats. Sawada Y; Hanano M; Sugiyama Y; Iga T J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813 [TBL] [Abstract][Full Text] [Related]
4. Drug metabolism in uremia. Reidenberg MM Clin Nephrol; 1975; 4(3):83-5. PubMed ID: 1102176 [No Abstract] [Full Text] [Related]
5. Effect of age and sex on the plasma binding of acidic and basic drugs. Verbeeck RK; Cardinal JA; Wallace SM Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive chemical methods of estimating pharmacokinetic parameters. Graham GG Pharmacol Ther; 1982; 18(3):333-49. PubMed ID: 6762568 [TBL] [Abstract][Full Text] [Related]
7. On the distribution of drugs in saliva and blood plasma. Feller K; le Petit G Int J Clin Pharmacol Biopharm; 1977 Oct; 15(10):468-9. PubMed ID: 21854 [TBL] [Abstract][Full Text] [Related]
8. Saliva phenobarbital and phenytoin concentrations in epileptic adolescents. Friedman IM; Litt IF; Henson R; Holtzman D; Halverson D J Pediatr; 1981 Apr; 98(4):645-7. PubMed ID: 7205497 [No Abstract] [Full Text] [Related]
9. Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring. Gorodischer R; Koren G Dev Pharmacol Ther; 1992; 19(4):161-77. PubMed ID: 1343619 [TBL] [Abstract][Full Text] [Related]
10. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs. Shrewsbury RP Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876 [TBL] [Abstract][Full Text] [Related]
15. Carbenoxolone interactions in man--preliminary report. Thornton PC; Papouchado M; Reed PI Scand J Gastroenterol Suppl; 1980; 65():35-9. PubMed ID: 6937939 [TBL] [Abstract][Full Text] [Related]
16. [Monitoring therapy by analysis of the drug concentration of saliva]. Bartels H; Günther E; Wallis S Monatsschr Kinderheilkd; 1983 Jan; 131(1):13-6. PubMed ID: 6835213 [TBL] [Abstract][Full Text] [Related]
17. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow. Branch RA; Shand DG; Wilkinson GR; Nies AS J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524 [TBL] [Abstract][Full Text] [Related]
18. [A study on cerebrospinal fluid and saliva to serum concentration ratios of anticonvulsants--Phenytoin, Phenobarbital, Valproic Acid and Primidone in epileptic patients]. Kido H Seishin Shinkeigaku Zasshi; 1982; 84(9):661-79. PubMed ID: 6820506 [No Abstract] [Full Text] [Related]
19. Concentration of antiepileptic drugs in persons with epilepsy: a comparative study in serum and saliva. Dwivedi R; Singh M; Kaleekal T; Gupta YK; Tripathi M Int J Neurosci; 2016 Nov; 126(11):972-8. PubMed ID: 26441313 [TBL] [Abstract][Full Text] [Related]
20. Elimination of antipyrine from saliva as a measure of metabolism in man. Welch RM; DeAngelis RL; Wingfield M; Farmer TW Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]